Clinical Trial Update: Assessment of Combined Praziquantel and Albendazole vs Albendazole Alone to Treat Active Parenchymal Neurocysticercosis [Phase 4]

View source ↗

Summary

A Phase 4 trial is planned to assess combining praziquantel with albendazole versus albendazole alone for active parenchymal neurocysticercosis; recruitment not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurocysticercosis

Drugs mentioned

• Albendazole (ALBENDAZOLE)
• Praziquantel (Praziquantel)

Snippet

Sponsor: R-Evolution Worldwide S.r.l. Impresa Sociale | Conditions: Neurocysticercosis | Phase 4 | Status: NOT_YET_RECRUITING